Mauna Kea Technologies Welcomes Jacquelien Ten Dam to Board of Directors
Regulatory News:
Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY) inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, announced today the cooptation by the Board of Ms. Jacquelien Ten Dam as an Independent Director, effective immediately. Ms. Ten Dam replaces Dr. Jennifer Tseng, who tendered her resignation from the Board after 3 years of service. This cooptation will be subject to the approval of the Ordinary General Meeting of Mauna Kea Technologies, which will be voting on the financial statements for the fiscal year ending December 31, 2020, to be held in 2021.